Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ASTELLAS PHARMA INCORPORATED (4503-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

22 May 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Medical-drugs(ALPMY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

22 May 2015 ValuEngine, Inc. 10 $49.00

ValuEngine Rating and Forecast Report for ALPMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

18 May 2015 ValuEngine, Inc. 10 $25.00

Astellas Pharma Inc.

Astellas Pharma Inc. - Company Report, is a source of comprehensive company data and information. The report covers the comp...

11 May 2015 MarketLine (a Datamonitor Company) 49 $50.00

Will Astellas Pharma Inc Deliver Long-Term Returns?

30 Apr 2015 Sadif Analytics Prime 11 $25.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

29 Apr 2015 GlobalData 78 $125.00

Wright Investors Service Comprehensive Report for Astellas Pharma Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Apr 2015 Wright Reports 56 $75.00

Astellas Pharma Inc: Upgraded to Good

09 Mar 2015 Sadif Analytics Prime 3 $10.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

03 Mar 2015 GlobalData 75 $125.00